Follicular lymphoma treatment cost in Spain typically involves a comprehensive diagnosis of lymphomas ranging from $1,900 to $4,000 and primary interventions like autologous bone marrow transplantation, which runs from $40,000 to $70,000. Total expenses depend on the disease stage, specific immunotherapy protocols, and the hospital tier. Patients generally save 30–80% compared to the United States. Major treatment hubs include Barcelona, Madrid, and Pamplona.
Typical Follicular Lymphoma Treatment Costs in Spain
Bookimed Expert Insight: High-risk or relapsed cases benefit most from JCI-accredited centers like Clinica Universidad de Navarra. They offer advanced onco-hematology with a 5.0-star rating. For complex pediatric cases, SJD Barcelona Children’s Hospital provides specialized molecular medicine. This center is ranked among Europe's top three pediatric institutions. Patients seeking high-volume expertise should consider Centro Médico Teknon. It performs over 23,500 operations annually and is preferred by international celebrities.
| Turkey | Austria | Spain | |
| Radiation therapy for colorectal cancer | from $7,000 | from $12,000 | from $10,000 |
| Chemotherapy for breast cancer | from $1,200 | from $15,000 | from $3,500 |
| Bone marrow transplantation | from $36,000 | from $140,000 | from $71,782 |
| Autologous bone marrow transplantation | from $31,500 | from $50,000 | from $40,000 |
| Allogenic bone marrow transplantation from an unrelated donor | from $80,000 | from $180,000 | from $150,000 |
Dr. Graupera heads the Hematology Oncology Department at Sant Joan De Déu – one of Europe's top children's hospitals. His research focuses on pediatric cancer treatments.
Children's Hematologist specializing in bone marrow transplantation – Dr. Rives Sola provides focused care for pediatric cases at SJD Barcelona Children’s Hospital.
Dr. Francesc Cobo Valien specializes in lymphoma treatment with over _doctor_8145_years_ of experience. He combines clinical practice with cutting-edge research.
Professor Bosch is a world-renowned leader in Chronic Lymphocytic Leukemia (CLL) and lymphoproliferative disorders, with innovations in hematological disease analysis and treatments.